Short answer
Teladoc Health, Inc. (TDOC) filed an 8-K current report with the SEC on July 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Teladoc announced financial results for Q2 2026 on July 29, 2026.
Teladoc Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Teladoc announced financial results for Q2 2026 on July 29, 2026
- Full results and investor-relevant metrics are contained in Exhibit 99.1, the attached earnings release
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $606.9M, down 4% YoY, with U.S. revenue down 6% and International revenue up 7%
- Integrated Care revenue $394.3M, up 1%, and adjusted EBITDA margin 16.5%, offsetting BetterHelp deterioration
- BetterHelp revenue $212.6M, down 12%, with adjusted EBITDA margin collapsing to 0.2% from 4.9%
- BetterHelp paying users fell 11% to 0.346M, while insurance-covered services reached $21.8M versus $2.1M
- Full-year outlook retains revenue of $2.362B-$2.447B and adjusted EBITDA of $271M-$303M, but BetterHelp revenue growth now ranges from negative 19.0% to negative 12.7%
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Teladoc Health, Inc. 8-K filings
Get the next TDOC 8-K as it lands
Follow TDOC for push alerts, or ask the research agent what this filing means.